Bristol Myers Squibb shared a post on LinkedIn:
“Colorectal cancer (CRC) remains a significant public health challenge as the third most commonly diagnosed cancer worldwide.
While it has historically been associated with older adults, cases are increasingly being diagnosed in younger age groups.
As Colorectal Cancer Awareness Month comes to a close, our commitment to advancing innovative research and therapies to help improve outcomes for people living with CRC continues.
Other articles from Bristol Myers Squibb.